Patients were randomized to receive acarbose ( Arm A ; n = @ ) or metformin ( Arm B ; n = @ ) or pioglitazone ( Arm C ; n = @ ) in addition to peginterferon alfa-@b ( @ g/kg/week ) plus ribavirin ( @-@ mg/day ) or just PR ( Arm D ; n = @ ) .